National
House panel adopts anti-gay amendments in defense bill
Amendments reaffirm DOMA, could disrupt ‘Don’t Ask’ repeal
Rep. Duncan Hunter introduced an amendment that could disrupt 'Don't Ask' repeal (Blade photo by Michael Key)
A House defense committee approved on Wednesday a series of anti-gay amendments as part of major Pentagon budget legislation aimed at disrupting the process for repealing “Don’t Ask, Don’t Tell” and at demonstrating support for the Defense of Marriage Act.
The most high-profile amendment came from Rep. Duncan Hunter (R-Calif.), who introduced a measure that would expand the certification requirement needed for repeal to include input from the four military service chiefs. The Republican-controlled House Armed Services Committee voted 33-27 in favor of adopting the measure as part of the fiscal year 2012 defense authorization bill.
The vote in favor of the Hunter amendment was mostly along party lines, although Reps. Todd Platts (R-Pa.) and Chris Gibson (R-N.Y.) voted against the measure. Rep. Mike McIntyre (D-N.C.) was the sole Democrat to vote in favor of the measure.
The repeal legislation signed into law in December allows for repeal of “Don’t Ask, Don’t Tell” after 60 days pass following certification from the president, the defense secretary and the chair of the Joint Chiefs of Staff. Hunter’s amendment would expand the certification requirement to include input from the uniform chiefs of staff for the Army, Navy, Air Force and Marine Corps.
Hunter, a Marine Corps veteran of Iraq and Afghanistan, billed the amendment as a means to ensure the uniform military leaders — which he described “the ones that are actually responsible for the men and women under their care” — are able to express their opinion before moving forward with “Don’t Ask, Don’t Tell” repeal.
“Right now as it stands, the only folks that have to sign on to this are the president, who has never been to war or in ground combat, Adm. [Mike] Mullen, who, with all due respect to him, has never been to ground combat in Iraq or Afghanistan, and Secretary Gates, a political appointee, who is a very fine gentleman, but has never been in ground combat in Iraq or Afghanistan,” Hunter said. “I, and others in this room, have more combat experience than the people who would sign off on the repeal of ‘Don’t Ask, Don’t Tell.'”
Hunter emphasized his amendment would require the service chiefs to issue certification only based on their belief that “Don’t Ask, Don’t Tell” repeal wouldn’t harm morale and unit cohesion for combat arms units under their jurisdiction. According to the Pentagon survey published in November, these units are the most skeptical about whether open service would cause a disruption in the U.S. military.
Involving the military service chiefs in the “Don’t Ask, Don’t Tell” repeal certification process could disrupt or delay open service in the U.S. military because some uniform leaders of the military — notably Marine Corps Commandant Gen. James Amos — expressed opposition to passing repeal legislation last year. Amos has since said the Marine Corps would work to implement open service.
Despite the concerns that were expressed last year, each of the service chiefs testified in April that the process for enacting “Don’t Ask, Don’t Tell” repeal has been proceeding smoothly. Some service chiefs — including Chief of Naval Operations Adm. Gary Roughead — have said they oppose any effort to expand the certification requirement and they believe the defense secretary would adequately represent their views in the certification process.
Many Republican committee members voiced support for the Hunter amendment as they expressed opposition to implementing open service in the U.S. military.
Rep. Doug Lamborn (R-Colo.) said he supported the amendment because the president, the defense secretary and the chairman of the Joint Chiefs of Staff had already backed “Don’t Ask, Don’t Tell” repeal before Congress acted to end the military’s gay ban.
“I always felt the deck was stacked when the three people who were supposed to sign off on it, agreed to and had all been on record ahead of time saying what their preference was,” Lamborn said. “This broadens it, and, I think, adds more objectivity to the whole matter, and I think that that’s really good thing.”
Rep. Steve Palazzo (R-Miss.) said he opposes “Don’t Ask, Don’t Tell” repeal because he hasn’t encountered one American or U.S. service member who wants an end to the anti-gay law. Despite his remarks, polls found that around 80 percent of Americans favored ending the military’s gay ban at the time Congress repealed the statute.
Palazzo added he had a visit earlier today from about 85 veterans of World War II and said he believes they’d be displeased with “Don’t Ask, Don’t Tell” repeal.
“I don’t think that they would look upon this as progress,” Palazzo said. “I don’t think they’d look at this as the sacrifices they made for our families, for our country, for our allies, future generations of Americans — to see their military go down in flames by implementing [an end] to the DADT policy. Our men and women in uniform deserve better.”
Rep. Adam Smith (Blade photo by Michael Key)
But Democrats on the committee defended repeal of the law that Congress passed last year and said the current repeal process is working well.
Rep. Adam Smith (D-Wash.), ranking Democrat on the House Armed Services Committee, said the Hunter amendment troubled him because it suggests the president and the defense officials identified in the repeal law aren’t capable of making critical defense decisions.
“It’s a very, very dangerous thing to say that the president of the United States, the commander in chief; the secretary of defense; and the chairman of the Joint Chiefs of Staff are somehow not quite qualified to make important military decisions,” Smith said. “These are the same people that decide whether or not we go to war. They made a decision on whether or not to kill Osama bin Laden.”
Rep. Chellie Pingree (D-Maine) directly responded to the view expressed by Palazzo that World War II veterans would be unhappy with “Don’t Ask, Don’t Tell” repeal.
“Let’s not fool ourselves,” Pingree said. “Some of those soldiers were gay as well, and many of them took a long time to admit to that, or come out on that, but they’ve all been courageous in doing so and I think that they can’t be characterized as a generation that doesn’t want to see this change in the military.”
Although the committee adopted the amendment as part of defense authorization, passing such a provision into law would be challenging because the Senate would have to agree to it during conference negotiations and Obama would have to sign the measure.
Further, defense officials have testified that certification could happen mid-summer, and the final version of the defense authorization will likely not reach the president’s desk until after that time, rendering Hunter’s provision useless.
Alex Nicholson, executive director of Servicemembers United, expressed skepticism that the adoption of the Hunter amendment would impair the U.S. military’s ability to move toward open service.
“Despite the passage of this amendment within the ever-hostile House Armed Services Committee, it is highly unlikely that such an amendment would ever pass the Senate and be signed by the president,” Nicholson said. “The offering of this amendment was a shameful and embarrassing waste of time. The service chiefs have unequivocally said that they do not want this extra burden forced upon them, so if Congress really values their advice on this issue they should take it and forget this unnecessary and unwanted amendment.”
Hunter’s amendment was one of three anti-gay amendments the House Armed Services Committee approved on Wednesday as part of the defense authorization bill. Other measures affirmed the panel’s commitment to DOMA, which prohibits federal recognition of same-sex marriage.
The DOMA-related amendments were apparently inspired by Navy guidance on same-sex marriage that was made public this week.The guidance, which is dated April 13 and signed by Chief of Navy Chaplains Rear Adm. Mark Tidd, indicated military bases could be used for same-sex marriage ceremonies in states where such unions are legal and that Navy chaplains can officiate same-sex marriage ceremonies if they so choose.
However, following an outcry from conservatives, the Navy rescinded the guidance and said further legal review on the issue was necessary.
Rep. W. Todd Akin (R-Mo.) introduced an amendment mandating that marriage ceremonies on military installations must comply with DOMA and that chaplains can only officiate in their official capacity over such ceremonies if they comply with the anti-gay law.
The committee adopted the amendment as part of the Pentagon budget legislation by a vote of 38-23. Republican members of the panel were unanimous in their support for the measure. Reps. McIntyre, Larry Kissell (D-N.C.) and Mark Critz (D-Pa.) joined with the GOP to vote in favor of the amendment.
Akin said the amendment was necessary because he believes the recent Navy guidance demonstrates that the U.S. military was willing to skirt federal law.
“There is a federal law on the books and the military has decided they’re going to ignore that law,” Akin said. “That’s a very serious question. Does that mean that the law code on our books is an a la carte menu? Does that mean that the military can decide they’re going to change the rules of engagement and how they’re going to interrogate prisoners or [enforce] whatever particular law suits their fancy?”
Rep. Susan Davis (D-Calif.), who opposed the amendment, said the Navy guidance was the result of the Pentagon looking at how the U.S. military would look after “Don’t Ask, Don’t Tell.”
“We asked them to deal with these issues and to speak specifically to them,” Davis said. “So, when a facility is made available to such events, individuals who meet all the requirements for use of those facilities should not be denied access to the facility because of sexual orientation.”
Davis added the amendment restricts the right of chaplains to exercise freely their religious beliefs if they want to officiate at same-sex marriage ceremonies.
“Many chaplains represent faith traditions in which marriages between same-sex couples are celebrated and to prohibit them from doing so — to do that would be an attack on their rights with this amendment,” Davis said.
Although the Navy has said it will revisit the guidance, Davis said she’s confident the service will reach the same conclusion it had come to before.
Rep. Vicky Hartzler introduced an amendment to ensure DOD policies comply with DOMA (Blade photo by Michael Key)
Another amendment came from Rep. Vicky Hartzler (R-Mo.), whose measure restated that the definition of marriage under DOMA as a union between one man and one woman applies to Defense Department regulations and policies.
The panel adopted the measure as part of the defense authorization bill by a vote of 39-28. The Republican members of the panel were unanimous in their support. Reps. McIntyre, Kissell and Silvestre Reyes (D-Texas) as well as Del. Madeleine Bordallo (D-Guam) joined the GOP to vote in favor of the measure.
Hartzler said the intention of the amendment was to reaffirm congressional support for DOMA and opposition to same-sex marriage.
“I think that this is a time for us in this Congress, the 112th Congress, to give our stance that we believe this is a wise policy and that marriage should be between a man and a woman,” she said.
But Smith, who opposed the measure, disputed the idea that the federal government should be involved in state regulation of marriage and questioned why the committee was taking up the issue when the panel’s area of jurisdiction is the U.S. military.
“I don’t think we need to be inserting into the Defense Authorization Act a Congress-wide view on how marriage should be defined, however we may feel,” Smith said.
Aubrey Sarvis, executive director of the Servicemembers Legal Defense Network, was particularly critical of what he said was invoking the more controversial debate over marriage in an attempt to derail “Don’t Ask, Don’t Tell” repeal.
“These adopted amendments to delay and derail repeal are a partisan political attempt to interject the same-sex marriage debate and other unrelated social issues into the NDAA where they have no place,” Sarvis said. “Make no mistake — these votes should be a wake-up call to supporters of open service that our work is not done. Our commitment to timely certification and repeal must be redoubled as we move to the House floor to defend the progress we have made to ensure that LGB patriots can defend and serve the country they love with honesty and integrity.”
Another anticipated anti-gay amendment didn’t see introduction before the committee on Wednesday. Palazzo was expected to introduce an amendment that would require conscience regulations for service members who have religious or moral objections to open service. His office didn’t immediately respond to the Washington Blade’s request for comment on why the measure wasn’t introduced.
After adopting the anti-gay amendments, the committee voted to report out the defense authorization bill to the floor by a vote of 60-1. Rep. John Garamendi (D-Calif.) was the sole panel member to vote against the legislation.
The Republican-controlled House will likely pass the defense authorization bill as a whole when the measure reaches the floor. A vote on the legislation could happen as soon as the week of May 23.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Kazakh president signs anti-LGBTQ propaganda bill
Top 10 LGBTQ local news stories of 2025
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
